Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat

A. Raines, D. Flockhart, K. L. Dretchen, A. Singh, D. Thacker, A. Yacobi, D. Moros, B. H. Levitt, D. Abernethy

Research output: Contribution to journalArticle

Abstract

DPB exerts anticonvulsant properties in rodents in the maximal electroshock test and against seizures and death produced by pentylenetetrazole. As with phénobarbital (PB), but unlike most barbiturates, neurotoxic doses of DPB are readily separable from anticonvulsant doses but unlike PB, DPB lacks significant hypnotic properties. DMMDPB shares anticonvulsant properties with DPB in the rat. Studies were undertaken to determine whether DMMDPB is converted to DPB in vivo. Male rats weighing 250 G were given DMMDPB in a dose of 150 mg/kg by gavage suspended in PEG 400 in a total volume of 1 ml and a 0.5 ml wash. Blood was sampled every 30 minutes for up to 7 hours. An HPLC method utilizing a solid phase extraction was developed for detection of DMMDPB and DPB. The limit of quantification was 0.5 (μg/ml. Serum levels of the order of 2.5 to 4 ug/ml were observed 3 hours after dosing and were still rising; in the one animal sampled until 7 hours, levels were 7 μg/ml and still rising. At no time after DMMDPB dosing could DMMDPB be detected. These data show complete conversion of DMMDPB to DPB and are consistant with slow absorption followed by rapid and complete pre-systemic conversion to DPB.

Original languageEnglish
JournalFASEB Journal
Volume10
Issue number3
StatePublished - 1996

Fingerprint

Rats
Acids
acids
rats
anticonvulsants
Anticonvulsants
dosage
barbiturates
Electroshock
Pentylenetetrazole
Barbiturates
Solid Phase Extraction
Weighing
seizures
solid phase extraction
blood serum
Hypnotics and Sedatives
Rodentia
Animals
Seizures

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Raines, A., Flockhart, D., Dretchen, K. L., Singh, A., Thacker, D., Yacobi, A., ... Abernethy, D. (1996). Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat. FASEB Journal, 10(3).

Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat. / Raines, A.; Flockhart, D.; Dretchen, K. L.; Singh, A.; Thacker, D.; Yacobi, A.; Moros, D.; Levitt, B. H.; Abernethy, D.

In: FASEB Journal, Vol. 10, No. 3, 1996.

Research output: Contribution to journalArticle

Raines, A, Flockhart, D, Dretchen, KL, Singh, A, Thacker, D, Yacobi, A, Moros, D, Levitt, BH & Abernethy, D 1996, 'Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat', FASEB Journal, vol. 10, no. 3.
Raines A, Flockhart D, Dretchen KL, Singh A, Thacker D, Yacobi A et al. Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat. FASEB Journal. 1996;10(3).
Raines, A. ; Flockhart, D. ; Dretchen, K. L. ; Singh, A. ; Thacker, D. ; Yacobi, A. ; Moros, D. ; Levitt, B. H. ; Abernethy, D. / Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat. In: FASEB Journal. 1996 ; Vol. 10, No. 3.
@article{f8805c927e154d349b138b7011d0649d,
title = "Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat",
abstract = "DPB exerts anticonvulsant properties in rodents in the maximal electroshock test and against seizures and death produced by pentylenetetrazole. As with ph{\'e}nobarbital (PB), but unlike most barbiturates, neurotoxic doses of DPB are readily separable from anticonvulsant doses but unlike PB, DPB lacks significant hypnotic properties. DMMDPB shares anticonvulsant properties with DPB in the rat. Studies were undertaken to determine whether DMMDPB is converted to DPB in vivo. Male rats weighing 250 G were given DMMDPB in a dose of 150 mg/kg by gavage suspended in PEG 400 in a total volume of 1 ml and a 0.5 ml wash. Blood was sampled every 30 minutes for up to 7 hours. An HPLC method utilizing a solid phase extraction was developed for detection of DMMDPB and DPB. The limit of quantification was 0.5 (μg/ml. Serum levels of the order of 2.5 to 4 ug/ml were observed 3 hours after dosing and were still rising; in the one animal sampled until 7 hours, levels were 7 μg/ml and still rising. At no time after DMMDPB dosing could DMMDPB be detected. These data show complete conversion of DMMDPB to DPB and are consistant with slow absorption followed by rapid and complete pre-systemic conversion to DPB.",
author = "A. Raines and D. Flockhart and Dretchen, {K. L.} and A. Singh and D. Thacker and A. Yacobi and D. Moros and Levitt, {B. H.} and D. Abernethy",
year = "1996",
language = "English",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Conversion of dimethoxymethyl-diphenylbarbituric acid (DMMDPB) to diphenylbarbituric acid (DPB) in the rat

AU - Raines, A.

AU - Flockhart, D.

AU - Dretchen, K. L.

AU - Singh, A.

AU - Thacker, D.

AU - Yacobi, A.

AU - Moros, D.

AU - Levitt, B. H.

AU - Abernethy, D.

PY - 1996

Y1 - 1996

N2 - DPB exerts anticonvulsant properties in rodents in the maximal electroshock test and against seizures and death produced by pentylenetetrazole. As with phénobarbital (PB), but unlike most barbiturates, neurotoxic doses of DPB are readily separable from anticonvulsant doses but unlike PB, DPB lacks significant hypnotic properties. DMMDPB shares anticonvulsant properties with DPB in the rat. Studies were undertaken to determine whether DMMDPB is converted to DPB in vivo. Male rats weighing 250 G were given DMMDPB in a dose of 150 mg/kg by gavage suspended in PEG 400 in a total volume of 1 ml and a 0.5 ml wash. Blood was sampled every 30 minutes for up to 7 hours. An HPLC method utilizing a solid phase extraction was developed for detection of DMMDPB and DPB. The limit of quantification was 0.5 (μg/ml. Serum levels of the order of 2.5 to 4 ug/ml were observed 3 hours after dosing and were still rising; in the one animal sampled until 7 hours, levels were 7 μg/ml and still rising. At no time after DMMDPB dosing could DMMDPB be detected. These data show complete conversion of DMMDPB to DPB and are consistant with slow absorption followed by rapid and complete pre-systemic conversion to DPB.

AB - DPB exerts anticonvulsant properties in rodents in the maximal electroshock test and against seizures and death produced by pentylenetetrazole. As with phénobarbital (PB), but unlike most barbiturates, neurotoxic doses of DPB are readily separable from anticonvulsant doses but unlike PB, DPB lacks significant hypnotic properties. DMMDPB shares anticonvulsant properties with DPB in the rat. Studies were undertaken to determine whether DMMDPB is converted to DPB in vivo. Male rats weighing 250 G were given DMMDPB in a dose of 150 mg/kg by gavage suspended in PEG 400 in a total volume of 1 ml and a 0.5 ml wash. Blood was sampled every 30 minutes for up to 7 hours. An HPLC method utilizing a solid phase extraction was developed for detection of DMMDPB and DPB. The limit of quantification was 0.5 (μg/ml. Serum levels of the order of 2.5 to 4 ug/ml were observed 3 hours after dosing and were still rising; in the one animal sampled until 7 hours, levels were 7 μg/ml and still rising. At no time after DMMDPB dosing could DMMDPB be detected. These data show complete conversion of DMMDPB to DPB and are consistant with slow absorption followed by rapid and complete pre-systemic conversion to DPB.

UR - http://www.scopus.com/inward/record.url?scp=33748969695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748969695&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -